equilar atlas seo  page not available    log in  sign up page not available please click here to continue browse individual profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z �  equilar inc    about    terms of use    executive rankings   avery catlin  celldex therapeutics  inc  zoominfocom crbp avery w catlin insider trades for corbus pharmaceuticals holdings inc bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close corbus pharmaceuticals holdings inc nasdaq crbp go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus corbus pharmaceuticals holdings inc after hours  quotes are delayed by  min jul    pm crbp quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual avery w catlin mr avery w catlin is independent director at corbus pharmaceuticals holdings inc cfo secretary treasurer  senior vice president at celldex therapeutics inc and chief financial officer at curagen corp he is on the board of directors at corbus pharmaceuticals holdings inc mr catlin was previously employed as chief financial officer secretary  svp by avant immunotherapeutics inc chief financial officer  vpoperations by endogen inc chief financial officer by repligen corp and chief financial officer by medisense inc he received his undergraduate degree from the university of virginia and an mba from babson college transactions date shares transaction value     acquisition at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr mark a tepper president  chief scientific officer dr yuval cohen chief executive officer  director mr sean f moran cfo  principal accounting officer dr barbara white chief medical officer mr david p hochman director mr alan f holmer chairman mr avery w catlin independent director dr renu gupta independent director log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pthe dark side of cruises pif you suddenly quit your job like sean spicer here’s what you should do next pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight p easily avoidable reasons why millennials can’t have nice things or save any money pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders phow elon musk and shorter commutes could transform people’s lives pbanks have raised creditcard interest rates — but not savings account rates pthe most expensive city in the world is not new york or san francisco p in  americans say they will die in debt pshopping at costco and  other things that prove rich people are cheap aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  cldx avery w catlin insider trades for celldex therapeutics inc bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close celldex therapeutics inc nasdaq cldx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus celldex therapeutics inc after hours  quotes are delayed by  min jul    pm cldx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual avery w catlin mr avery w catlin is independent director at corbus pharmaceuticals holdings inc cfo secretary treasurer  senior vice president at celldex therapeutics inc and chief financial officer at curagen corp he is on the board of directors at corbus pharmaceuticals holdings inc mr catlin was previously employed as chief financial officer secretary  svp by avant immunotherapeutics inc chief financial officer  vpoperations by endogen inc chief financial officer by repligen corp and chief financial officer by medisense inc he received his undergraduate degree from the university of virginia and an mba from babson college transactions date shares transaction value     derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share       copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr anthony s marucci president chief executive officer  director mr sam martin chief financial officer  senior vice president dr tibor keler chief scientific officer  executive vp dr thomas andrew davis chief medical officer  executive vice president ms sarah boylan cavanaugh senior vpcorporate affairs  administration ms elizabeth crowley chief product development officer  svp dr ronald a pepin chief business officer  senior vice president dr richard wright chief commercial officer  senior vice president mr keith l brownlie director mr james j marino director dr gerald mcmahon director dr theresa m lavallee senior vpregulatory  precision medicine mr larry ellberger chairman ms karen lipton shoos independent director mr george o elston independent director mr harry h penner independent director mr herbert j conrad independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pthe dark side of cruises pif you suddenly quit your job like sean spicer here’s what you should do next pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight p easily avoidable reasons why millennials can’t have nice things or save any money pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders phow elon musk and shorter commutes could transform people’s lives pbanks have raised creditcard interest rates — but not savings account rates pthe most expensive city in the world is not new york or san francisco p in  americans say they will die in debt pshopping at costco and  other things that prove rich people are cheap aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates avery w catlin home search signinup contracts dictionary clauses companies people about faq blog follow avery w catlin contracts click to signup for email updates loading home sample contracts by executive avery w catlin avery w catlin sec documents filings personal financials insider transactions previous companies celldex therapeutics nasdaqcldx sample contracts with avery w catlin second amendment to lease february rd  this second amendment to lease this amendment is dated as of august   by and between div needham  llc a massachusetts limited liability company successorininterest to fourth avenue ventures limited partnership as landlord landlord and celldex therapeutics inc a delaware corporation successorby namechange to t cell sciences inc and avant immunotherapeutics inc as tenant tenant with respect to that certain lease dated as of may   the  lease as amended by that certain first amendment to lease dated as of november   the first amendment the  lease as amended by the first amendment is referred to herein as the original lease and the original lease as amended hereby is referred to herein as the lease by and between landlord and tenant regarding certain premises the existing premises constituting approximately  rentable square feet on the first st floor of the building located at  fourth avenue needham massac eighth amendment to lease february rd  this eighth amendment to lease this amendment is made as of the st day of november  the effective date by and between university of massachusetts dartmouth an institution of higher education of the commonwealth of massachusetts with an address of  old westport rd north dartmouth massachusetts  landlord and celldex therapeutics inc formerly avant immunotherapeutics inc a delaware corporation with an address of  fourth avenue needham massachusetts tenant employment agreement december st  this employment agreement the agreement is entered into this st day of january  the effective date between avery w catlin the executive and celldex therapeutics inc a delaware corporation the company collectively the executive and the company shall be referred to as the parties in consideration of the mutual promises and agreements contained herein the parties agree as follows celldex therapeutics inc controlled equity offeringsm amendment no  to sales agreement september th  amendment to celldex therapeutics inc  stock option and incentive plan as amended and restated effective as of february   dated april   june th  this agreement amends the celldex therapeutics inc  stock option and incentive plan as previously amended and restated effective as of february   the plan all capitalized terms not defined herein shall have the meanings set forth in the plan amendment to security agreement december rd  this amendment to security agreement is made as of january   by and between celldex therapeutics inc successor in interest to avant immunotherapeutics inc borrower and massachusetts development finance agency a body politic and corporate created under massachusetts general laws chapter g lender amendment to loan documents december rd  this amendment to loan documents is made as of january   by and between celldex therapeutics inc successor in interest to avant immunotherapeutics inc borrower and massachusetts development finance agency a body politic and corporate created under massachusetts general laws chapter g lender allonge to promissory note december rd  this allonge to promissory note is made as of january   by and between celldex therapeutics inc successor in interest to avant immunotherapeutics inc a delaware corporation borrower and massachusetts development finance agency a body corporate and politic created under massachusetts general laws chapter g lender second amendment to the shareholder rights agreement march th  second amendment dated as of march   this amendment to the shareholder rights agreement dated as of november   the rights agreement by and between avant immunotherapeutics inc a delaware corporation the company and computershare trust company na formerly equiserve trust company na as rights agent the rights agent terms used herein but not defined shall have the meaning assigned to them in the rights agreement third amendment to amended and restated employment agreement october rd  this third amendment to amended and restated employment agreement amendment by and between avant immunotherapeutics inc a delaware corporation fka t cell sciences inc the company and una s ryan phd the executive is dated as of october   third amendment to amended and restated employment agreement october rd  this third amendment to amended and restated employment agreement amendment by and between avant immunotherapeutics inc a delaware corporation fka t cell sciences inc the company and una s ryan phd the executive is dated as of october   first amendment to the shareholder rights agreement october nd  first amendment dated as of october   this amendment to the shareholder rights agreement dated as of november   the rights agreement by and between avant immunotherapeutics inc a delaware corporation the company and computershare trust company na formerly equiserve trust company na as rights agent the rights agent terms used herein but not defined shall have the meaning assigned to them in the rights agreement avant immunotherapeutics inc and equiserve trust company na as rights agent shareholder rights agreement dated as of november   november th  agreement dated as of november   between avant immunotherapeutics inc a delaware corporation the company and equiserve trust company na a national trust company the rights agent lease from massachusetts development finance agency landlord to avant immunotherapeutics inc april th  secured promissory note equipment loan summary of terms and definitions date of note april th  the term lender shall include successors and assigns of massachusetts development finance agency and any future holder of this note and any participants in this note confidential treatment requested as to certain information contained in this exhibit security agreement equipment dated and effective as of december   april th  whereas massachusetts development finance agency a body politic and corporate and a public instrumentality under the laws of the commonwealth of massachusetts with its principal office at  federal street boston massachusetts  together with its successors andor assigns the lender has agreed to make a loan to avant immunotherapeutics inc a delaware corporation with its principal office located at  fourth avenue needham massachusetts  the debtor such loan being evidenced by that certain secured promissory note equipment loan made by debtor as of the date hereof to the order of the lender the note this security agreement the note and any ucc financing statements executed in connection with this security agreement as each may be amended or modified from time to time are referred to herein collectively as the loan documents follow avery w catlin contracts click to signup for email updates loading × have an account sign in here law insider recover your password no account register now no account register now sign in by using one of this services or forgot your password have an account sign in here join law insider for free by using one of this services or by registering you agree to our terms of service contract and agreement category list home search signinup contracts dictionary clauses companies people about faq blog sample contract categories a b c d e f g h i j k l m n o p q r s t u v w x y z abcdefghijklmnopqrstuvwxyz k delaware k new york k california k texas k agreement k nevada k florida k maryland k illinois k employment agreement k washington k amended and restated k massachusetts k new jersey k pennsylvania k georgia k colorado k ohio k minnesota k virginia k north carolina k incentive plan k credit agreement k amendment k connecticut k michigan k indiana k registration rights agreement k recitals k tennessee k arizona k missouri k purchase agreement k promissory note k indenture k warrant k louisiana k kansas k utah k wisconsin k oklahoma k securities purchase agreement k agreement and plan of merger k iowa k supplemental indenture k note k equity incentive plan k kentucky k stock purchase agreement k alabama × have an account sign in here law insider recover your password no account register now no account register now sign in by using one of this services or forgot your password have an account sign in here join law insider for free by using one of this services or by registering you agree to our terms of service management  about  celldex therapeutics careers        contact      about overview management board of directors scientific advisory board business development careers overview benefits current opportunities locations pipeline overview glembatumumab vedotin varlilumab cdx cdx cdx cdx cdx science overview publications clinical trials overview compassionate use investors  media investor relations press releases events  presentations stock information overview stock chart historic stock lookup investment calculator irs form  financial  sec reports overview sec filings annual reports quarterly results corporate governance overview management board of directors committee composition analyst coverage email alerts contact us overview management board of directors scientific advisory board business development careers overview benefits current opportunities locations management anthony s marucci founder president chief executive officer and director mr marucci is a founder of celldex and serves as the company’s president and chief executive officer and as a member of the board of directors prior to his appointment as president and ceo in  mr marucci served as vice president chief financial officer treasurer and secretary of celldex celldex founded in  as a subsidiary of medarex medarex is now a whollyowned subsidiary of bristol myers squibb was initially spun out as an independent private company in october  with the asset acquisition of cdx from alteris therapeutics inc and the acquisition of lorantis limited cambridge uk in addition to these acquisitions mr marucci is also responsible for the avant immunotherapeutics inc and celldex therapeutics inc merger completed during the first quarter of  and the acquisition of curagen corporation completed in the third quarter of  he was treasurer of medarex from december  to march  where he held a series of senior financial positions since december  he is a member of the board of trustees of bionj and also served as its treasurer through  mr marucci received a bs in accounting from kean university an mba from columbia university and an executive master of healthcare leadership emhl from brown university sarah cavanaugh senior vice president corporate affairs and administration ms cavanaugh joined celldex in august  as vice president of investor relations and corporate communications prior to joining celldex she served from  to  as a vice president at macdougall biomedical communications a strategic communications and investor relations firm for the life sciences industry where she developed and implemented programs for more than  biopharmaceutical companies and served as the inhouse oncology expert ms cavanaugh has served in a number of leadership positions in the health care and life sciences industry including director of corporate communications for point therapeutics an oncologyfocused biotech company and director of corporate communications for fallon community health plan a leading massachusetts managed care organization she began her health care career at the american cancer society holding various positions providing leadership in physician education corporate communications government relations and marketing she completed her tenure there as division communications and marketing director for the midsouth division where she was responsible for managing the efforts of marketing and communications staff across six states throughout her career ms cavanaugh has played a leadership role in organizational development and employee relationscommunication ms cavanaugh received her ba from the university of new hampshire elizabeth crowley senior vice president chief product development officer elizabeth crowley is senior vice president chief product development officer of celldex ms crowley joined celldex in  as vice president clinical development prior to that she held several senior level roles at curagen corporation most recently serving as the vice president of development operations responsible for strategic and operational development activities of the oncology and oncology supportive care portfolio regulatory affairs clinical operations and data management ms crowley started her career at bayer corporation in  holding various positions providing leadership of clinical research and project management prior to completing her tenure there as the director of global study audit management assuring the highest standards for program execution ms crowley received her bs in chemistry with a concentration in business from boston college thomas davis md executive vice president and chief medical officer dr davis is executive vice president and chief medical officer of celldex prior to this appointment in  he was senior vice president of clinical development and chief medical officer of celldex formerly he was chief medical officer at genvec and senior director of clinical science at medarex he has supervised clinical efforts in adult hematologic malignancies and marrow transplantation and therapeutic antibodies and vaccines at the cancer therapy evaluation program ctep of the national cancer institute nci and worked with dr ron levy on the development of rituximab and idiotype vaccines at stanford university dr davis received his ba in biophysics from johns hopkins ms in physiology and md from georgetown university and oncology training at stanford university tibor keler phd founder executive vice president and chief scientific officer dr keler is a founder of celldex and serves as the company’s executive vice president and chief scientific officer prior to this appointment in  he was senior vice president of research and discovery at celldex celldex founded in  as a subsidiary of medarex medarex is now a whollyowned subsidiary of bristol myers squibb was initially spun out as an independent private company in october  with the asset acquisition of cdx from alteris therapeutics inc and the acquisition of lorantis limited cambridge uk previously dr keler was senior director of preclinical development and principal scientist at medarex from september  to march  while at medarex he was responsible for the preclinical development of a number of medarex clinical product candidates in addition dr keler was responsible for the development of celldexs core technology and related products dr keler received his phd in microbiology from the university of pennsylvania sam martin senior vice president and chief financial officer mr martin joined celldex in april  as director of financial reporting planning and analysis and most recently served as vice president finance prior to joining celldex mr martin served as the director of finance and corporate compliance for alseres pharmaceuticals where he was responsible for managing the financial and sec reporting and the annual budget and planning process mr martin began his career at ernst  young holding various positions prior to completing his tenure as audit manager where he provided audit review due diligence and consulting services to public and private companies in the biotechnology medical device health care high technology manufacturing and consumer product industries mr martin received an mba from boston university a bs from skidmore college and is a certified public accountant ronald a pepin phd senior vice president and chief business officer dr pepin joined celldex in july  as senior vice president and chief business officer he previously served as vice president at shire pharmaceuticals from  –  as senior vice president business development at medarex inc he was instrumental in establishing more than forty collaborations with global biopharmaceutical companies earlier in his career he served as executive director of external science and technology at bristolmyers squibb dr pepin received his ba from tufts university and his phd in genetics from georgetown university richard wright phd senior vice president and chief commercial officer dr wright is senior vice president and chief commercial officer of celldex he joined celldex in  as vice president of commercial operations prior to celldex dr wright was managing director at navigant consulting where he led a life sciences practice focused on commercial strategy for oncology immunology and rare disease therapies previously dr wright was at bristolmyers squibb where he held senior leadership roles including senior vice president of the us immunology business and vice president and global commercial lead for the immunology franchise at bristolmyers squibb he was responsible for ctlaig immunotherapies including the blockbuster drug orencia® and the orphan drug nulojix® in these roles he was charged with setting overall business strategy commercializing the company’s broad immunology franchise and managing the us marketing and sales organizations dr wright began his career at novartis pharmaceuticals sandoz where he led research aimed at discovering novel inhibitors of cell migration and metastasis inhibition of tumorinduced angiogenesis and induction of immune tolerance at novartis he later held several roles in new product commercialization marketing and salesforce leadership in its transplant and immunology business unit and was responsible for neoral® simulect® certican® and myfortic® dr wright received his bs in biological sciences from rutgers university and his ms and phd in microbiology and molecular genetics from the university of medicine and dentistry of new jersey rutgers university he received an mba in marketing and finance from columbia university   about us celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate our pipeline includes antibodies antibodydrug conjugates and other proteinbased therapeutics derived from a broad set of complementary technologies which have the ability to engage the human immune system andor directly inhibit tumors to treat specific types of cancer or other diseases   our pipeline about overview management board of directors scientific advisory board business development careers locations pipeline overview glembatumumab vedotin varlilumab cdx cdx cdx cdx cdx science overview publications clinical trials overview compassionate use investors  media investor relations press releases events  presentations stock information financial  sec reports corporate governance analyst coverage email alerts contact us   celldex therapeutics all rights reserved  site map  privacy policy  terms of use  contact avery w catlins involvement in venture capital via celldex therapeutics inc want to see morewant to find out who got funded and who’s funding the next big thing in real time all across the world tailored to your specific areas of focus deals per dayget access to the most exhaustive worldwide funding watch on the webcomprehensive funding informationknow about who invested in a company which sites covered the event the funding history etcexclusive insightsview original analytics such as most dynamic industries most active investors and morestay awareget emailed when deals critical to your business happen filter by region industry and topics of interestas seen onhave a loginsign inregister nowits freeuse your social accountor fill in the quick formregister nowpromise we wont spamsign invia your social accountvia your existing wgf accountremember meregister its freeforgot your passwordsign inforgot your passwordenter your email and we will send you your new passwordreset passwordthe worlds largest funding basepeoplewcatlinaverysectionpeoplesubsectiondetailid search deals by company name industry location investors search averyw catlinget alertedif avery w catlin gets fundedavery w catlincelldex therapeutics inc  svp  cfodeals involving avery w catlin raised with celldex therapeutics inc on october  raised with celldex therapeutics inc on december please note that all data is automatically extracted and errors can occurthe whogotfunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and completesome of the profile information was collected using the crunchbase api for more details on the profile please check avery w catlin on crunchbaseinaccurate data help us improve whogotfunded post a comment